Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. - Wikidata - awgldk - TriplyDB

Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy.

Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy.

http://www.wikidata.org/entity/Q35699115

about

Angiotensin receptors, autoimmunity, and preeclampsia Pathophysiology of placentation abnormalities in pregnancy-induced hypertension The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia Renal function in normal and disordered pregnancy The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia.Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity.B cells: the old new players in reproductive immunology.Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy Targeted expression of Cre recombinase provokes placental-specific DNA recombination in transgenic mice.Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia.Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia.Placentation abnormalities in the pathophysiology of preeclampsia.Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes.Placenta-specific miRNA (miR-512-3p) targets PPP3R1 encoding the calcineurin B regulatory subunit in BeWo cells.Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemia/hypoxia: role of angiotensin II.Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling.Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice.Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice.Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia.Renin angiotensin signaling in normal pregnancy and preeclampsia.Human placental expression of SLIT/ROBO signaling cues: effects of preeclampsia and hypoxia Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling.Is preeclampsia an autoimmune disease?International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats Angiogenic factors in preeclampsia and related disorders Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α.Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction.Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women.The functional role of the renin-angiotensin system in pregnancy and preeclampsia.The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage.Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension.Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection.Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension.

P2860

Q24605647-56699220-6B93-49B9-9E0C-119382A731FB Q24649934-DC1BF645-5C69-4DAE-BFA5-03E94E78F21B Q26798193-82D5CE9C-A0EE-4562-AD59-6573B236DCE9 Q33411571-58D039E0-9574-465E-A20F-6EFD64B25094 Q33591058-50A20628-6B2B-4B6A-8A8D-DFE57387B746 Q33748680-41821C46-9A6F-4B4D-9509-A780E3B8F1A3 Q33789436-0E541514-01BA-4E96-9465-D2FBF2EC810F Q33893203-58BD0354-CCA7-41A4-8D07-15A8C6D11311 Q34169819-2461A178-DAAB-4FEA-B8A4-22BB06F81EE9 Q34341543-8AE5124C-0C5E-44E9-9975-202814BAEE71 Q34655258-C009E241-7E03-4C93-B788-8B1E9C1ADF7C Q34731047-7F8893B2-02F1-4370-B341-0C06A85DABFB Q34908922-BFFC9346-FF02-42B0-B8D0-8624A79C2D84 Q35029700-3FFE3914-853B-496D-A55E-4C3232953D42 Q35045834-4098C429-1C7C-4659-AF4C-0A305999BD91 Q35140024-ED708203-90D5-4A3C-BAFE-FB411CA3D6FA Q35363716-F8A6094C-F76F-4CFD-BCD6-1D28F040B9CD Q35681804-17F26DBD-8777-4CA7-82F8-6A06EA7DC8A1 Q35681821-E34C3DBF-3C69-436E-A57C-E80B161AFBE7 Q35683468-8514E55F-9031-42AD-9830-9F8F731C2A99 Q35701236-31590BFB-C3F0-45D8-8431-E913E1C3080B Q35715914-E271FE31-7B2A-44CE-B8EA-A017C186007D Q35743816-BD350D74-49BE-41EF-A7E5-7E715668642F Q35918271-7669DBA8-525B-42D0-8AB9-2CAF41444684 Q36050771-A02971A7-2341-4E74-BD89-C59FFBF3DCD2 Q36050775-4AEF5783-8FE8-4E07-A2E8-C78A285A67E4 Q36241932-66D34442-5A33-4433-AAD5-83A6F3DFD6A7 Q36339273-0003FD8E-BFB9-42F5-ADC3-7DBECA94EAB9 Q36526596-A7CC05FF-5DFA-471A-B93A-6AE6719AA3D3 Q36528002-836AD016-F2B0-4590-A719-9F892C005655 Q36965155-FAF0DBF7-0950-4697-B137-C42BEF15AB06 Q37022723-8FB64BC1-C9C8-4B63-8283-509B2FFEC890 Q37024446-0881DF85-2AFE-40C7-9162-F0BC09CD4640 Q37039872-85380175-1F6A-41E7-96E6-E5E0F994F05E Q37041658-6F1CD4BD-FBAA-4A6A-B592-0B37C7F028AC Q37114991-CACE64E9-B4CC-485A-AEBF-9EF2E9F73C4F Q37346569-06F5E5C4-4F48-44BD-A02B-5C65609F8168 Q37353499-4C684D8E-3034-4495-BBF4-E50875861CB6 Q37362662-6F79DF2E-8D66-42A4-B693-EB30DB5732F3 Q37454990-1A462C32-B472-4EC3-9C6D-59A352B96007

P2860

Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy.

http://www.wikidata.org/entity/Q35699115

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Angiotensin II induces soluble ...... ignaling pathway in pregnancy.

@ast

Angiotensin II induces soluble ...... ignaling pathway in pregnancy.

@en

type

label

Angiotensin II induces soluble ...... ignaling pathway in pregnancy.

@ast

Angiotensin II induces soluble ...... ignaling pathway in pregnancy.

@en

prefLabel

Angiotensin II induces soluble ...... ignaling pathway in pregnancy.

@ast

Angiotensin II induces soluble ...... ignaling pathway in pregnancy.

@en

P1433

Q35699115-66396698-E7A4-4EA2-98E5-8AF3D32EEF25

P1476

Q35699115-3977F9C0-A4B8-4A3D-A6A5-483136142491

P2093

Q35699115-0EF9F62F-3EB5-440B-8353-6E5F4DCC39DF

Q35699115-34FBA080-9EB1-41A4-B0F9-36D88DADC2E7

Q35699115-67B852A6-ACFE-4DF7-82DB-1A5151C5737D

Q35699115-73E602BD-7FC7-4D47-B64F-244514DD41A8

Q35699115-82FADBDE-BEB2-401C-8621-218D54A5DD9A

Q35699115-B9402ABE-4320-492C-B8E0-6FED69D3F567

Q35699115-BBA8342A-B3CD-474F-BACE-95C5E7569E2F

Q35699115-DB43644D-135E-4768-9800-601B06DD3161

Q35699115-E6E5F27F-6A5A-4CEF-A362-4993E23A271D

P2860

Q35699115-026D7A09-563C-4A15-9C3F-E8D8FA65E107

Q35699115-041807A7-407F-4C42-A411-C937FA3F2B88

Q35699115-0E98D5B0-A8AA-477E-9CEA-897DD21C5B85

Q35699115-10CDF720-FC75-47EF-91ED-19A8B9F6B38A

Q35699115-1121EA99-8893-42D8-8B4C-C4A2AB4195C3

Q35699115-1D622435-1170-4A84-AC0F-39D42885709B

Q35699115-1F18CD85-1AC9-4301-97B9-ABFEA730AA41

Q35699115-1FFFA68E-7300-4A90-963F-5A6BB8782C65

Q35699115-24EE3D67-D0E6-495F-81E1-080007666B4F

Q35699115-25A0B214-BD8F-472B-AE59-E7C736F378C8

P304

Q35699115-3CA76A4D-33F9-4C5E-94CD-9D13A9CFA95A

P31

Q35699115-34FD1443-A566-4EF4-8A98-D4007D8CF7DB

P356

Q35699115-28608D01-4E5E-48DC-838E-6A38FAA8013D

P433

Q35699115-3B1B6BFE-6FA2-4B0B-9ACC-A85D977CE649

P478

Q35699115-6FE9FDCF-C641-4064-8FF3-3021BCA2C47D

P50

Q35699115-55361E4D-B028-4602-862B-E1E59D0196FA

P577

Q35699115-81A0FC3E-3F3E-43E1-BEE4-63B099C7C6A9

P5875

Q35699115-9CF420C1-CFE3-4F61-B3FE-5887BA753386

P698

Q35699115-B413963F-6131-42F7-97D7-DF6E68FD520A

P932

Q35699115-E0EA67AF-53F8-42A4-ADE9-A87BAA2789BB

P356

01.RES.0000254703.11154.18

P1433

Circulation Research

P1476

Angiotensin II induces soluble ...... ignaling pathway in pregnancy.

@en

P2093

Asif Ahmed

http://www.w3.org/2001/XMLSchema#string

ChunXiao Sun

http://www.w3.org/2001/XMLSchema#string

Cissy Chenyi Zhou

http://www.w3.org/2001/XMLSchema#string

Lingwei Xia

http://www.w3.org/2001/XMLSchema#string

Peter W Hewett

http://www.w3.org/2001/XMLSchema#string

Rodney E Kellems

http://www.w3.org/2001/XMLSchema#string

Shahrzad Abbasi

http://www.w3.org/2001/XMLSchema#string

TieJuan Mi

http://www.w3.org/2001/XMLSchema#string

Yang Xia

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Serial analysis of gene expression in mouse kidney following angiotensin II administration.

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review.

A study of angiotensin II pressor response throughout primigravid pregnancy.

Physiology of local renin-angiotensin systems.

P304

88-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.RES.0000254703.11154.18

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6642014

http://www.w3.org/2001/XMLSchema#string

P698

17158338

http://www.w3.org/2001/XMLSchema#string

P932

3266823

http://www.w3.org/2001/XMLSchema#string